쿼드메디슨

464490KOSDAQ기초 의약물질 제조업

44.3 / 100

Reference Date: 2026-07-24

Financial Score11.0 / 40

News Sentiment18.3 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, Operating Profit is on a declining trend. Declined 6.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

QuadMedison develops next-generation drug delivery systems using micro needle platform technology, expanding its business through Contract Development and Manufacturing Organization (CDMO) agreements with pharmaceutical companies. The company's core technologies, including S-MAP, C-MAP, and P-MAP, enhance medication compliance and offer innovative solutions for vaccines and synthetic pharmaceuticals.

Number of Employees

90people

Average Salary

51.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 25.444.0Point

PBR

2.19Industry Average 1.261.0Point

1.7x industry avg (risky)

ROE

-32.69Industry Average -6.033.5Point

5.4x industry avg (excellent)

Debt Ratio

31.04Industry Average 6.620.0Point

4.7x industry avg (risky)

Trend 2024~20252.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲15.0% (1-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼43.5% (1-year basis)

ROE Trend

0.0 / 4

Avg ROE -40.5% (improving, 2yr)

Detailed News Sentiment

6 totalPositive 4Neutral 2Negative 0Average Sentiment Score 73.3

Neutral
에이치엘지노믹스 상장[증시캘린더]
에이치엘지노믹스의 코스닥 상장 소식은 시장에 관심을 유발하지만, 직접적인 영향은 제한적이다.
Neutral
레메디 상장·에이치엘지노믹스 청약[증시캘린더]
레메디의 코스닥 상장 소식은 관련 산업에 관심을 유발하지만, 쿼드메디슨의 직접적인 영향은 미미하다.
Positive
HL지노믹스, 한림 품 벗어나 '마이크로니들' 승부수
쿼드메디슨과의 협력으로 마이크로니들 신사업 진출이 예상되어 에이치엘지노믹스의 성장 가능성이 높아짐.

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 5,870Won52-week high 24,55052-week low 5,340

1-month return2.0Point

1m -6.38% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-22
Neutral주식등의대량보유상황보고서(일반)2026-07-22
Neutral[기재정정]사업보고서 (2025.12)2026-07-06